Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma

Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma

Collagen type VI alpha 6 chain (COL6A6), a novel collagen, has been considered as a tumor suppressor and therapeutic target in several tumors. However, the functional role of COL6A6 in immune cell infiltration and prognostic value in lung adenocarcinoma (LUAD) remains unknown. Here, we evaluated COL...

Full description

Bibliographic Details
Main Authors:	Yi Ma, Mantang Qiu, Haifa Guo, Haiming Chen, Jiawei Li, Xiao Li, Fan Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Oncology
Subjects:	lung adenocarcinoma COL6A6 tumor microenvironment prognosis signature nomogram
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.633420/full

Similar Items

Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma
by: Yaxin Chen, et al.
Published: (2022-10-01)

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma
by: Yaxin Chen, et al.
Published: (2023-11-01)

A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
by: Xuewen Wang, et al.
Published: (2022-07-01)

Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma
by: Jian Ji, et al.
Published: (2023-08-01)

Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1
by: Yu Q, et al.
Published: (2021-02-01)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
by: Yong Liu, et al.
Published: (2022-01-01)

The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma
by: Jinchao Zhu, et al.
Published: (2022-11-01)

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
by: Yimeng Cui, et al.
Published: (2022-09-01)

A Schematic Approach to Defining the Prevalence of COL VI Variants in Five Years of Next-Generation Sequencing
by: Gemma Marinella, et al.
Published: (2022-11-01)

Retrospective clinical and genetic analysis of COL6-RD patients with a long-term follow-up at a single French center
by: Victor Morel, et al.
Published: (2023-12-01)

A novel variant of COL6A3 c.6817-2(IVS27)A>G causing Bethlem myopathy: A case report
by: Maohua Li, et al.
Published: (2023-01-01)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
by: Fangwei Li, et al.
Published: (2020-08-01)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
by: Junjun Sun, et al.
Published: (2021-08-01)

Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma
by: Na Luo, et al.
Published: (2022-06-01)

The impact of COL1A1 and COL6A1 expression on hypospadias and penile curvature severity
by: Prahara Yuri, et al.
Published: (2020-12-01)

Extracellular Matrix Disorganization and Sarcolemmal Alterations in COL6-Related Myopathy Patients with New Variants of COL6 Genes
by: Simona Zanotti, et al.
Published: (2023-03-01)

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
by: Cheng Yue, et al.
Published: (2019-11-01)

Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma
by: Lei Guo, et al.
Published: (2022-12-01)

Study of the collagen type VI alpha 3 (COL6A3) gene in Parkinson’s disease
by: Chong-Yao Jin, et al.
Published: (2021-05-01)

Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma
by: Ji KE, et al.
Published: (2022-05-01)

Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
by: Lulu He, et al.
Published: (2020-12-01)

MYL6B drives the capabilities of proliferation, invasion, and migration in rectal adenocarcinoma through the EMT process
by: Li Jin-Liang, et al.
Published: (2020-08-01)

A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
by: Qiujuan Huang, et al.
Published: (2021-05-01)

Identification of a m6A-related ferroptosis signature as a potential predictive biomarker for lung adenocarcinoma
by: Dongdong Li, et al.
Published: (2023-04-01)

Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma
by: Teng Mu, et al.
Published: (2022-04-01)

Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma
by: Lele Zhang, et al.
Published: (2020-09-01)

Expression Status and Prognostic Value of m<sup>6</sup>A RNA Methylation Regulators in Lung Adenocarcinoma
by: Xiuhong Li, et al.
Published: (2021-06-01)

Identification of clinical prognostic features of esophageal cancer based on m6A regulators
by: Huimei Wang, et al.
Published: (2022-09-01)

Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m6A Regulators in Early-Stage Lung Adenocarcinoma
by: Bolun Zhou, et al.
Published: (2021-09-01)

ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis
by: Yuan Lin, et al.
Published: (2023-03-01)

Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
by: Zedong Li, et al.
Published: (2020-03-01)

Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma
by: Chang Gu, et al.
Published: (2021-03-01)

Inhibition of Col6a5 Improve Lipid Metabolism Disorder in Dihydrotestosterone-Induced Hyperandrogenic Mice
by: Li-Feng Sun, et al.
Published: (2021-05-01)

Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in COL4A6 and COL4A5
by: Xi Zhou, et al.
Published: (2021-10-01)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
by: Shaobo Mo, et al.
Published: (2021-06-01)

Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis
by: Yuexian Li, et al.
Published: (2021-06-01)

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
by: Xie H, et al.
Published: (2021-11-01)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
by: Yongfei Fan, et al.
Published: (2022-05-01)

Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I–III lung adenocarcinoma
by: Yongqiang Zhang, et al.
Published: (2023-07-01)

Bethlem myopathy demonstrated in three generations of a rural West Virginia family carrying an autosomal dominant COL6A3 mutation
by: Holly Farkosh, et al.
Published: (2021-07-01)